Alexion under HHS investigation as part of DOJ Medicare probe
Fierce Pharma ------ The U.S. Attorney’s Office for the District of Massachusetts isn’t the only one investigating Alexion over its support of organizations that help Medicare patients. The U.S. Department of Health and Human Services’ Office of Inspector General—which probes potential waste, fraud and abuse in Medicare, Medicaid and other HHS programs—is investigating the situation, too. As the OIG told Bloomberg Thursday, there is an “open and ongoing investigation” into the Connecticut biotech, which said in a statement that it is “aware” that the OIG is “working on this inquiry with the U.S. Attorneys’ Office and the Department of Justice.” “At this time, Alexion has not received a request for records from the HHS Office of Inspector General pertaining to any other matter,” a spokeswoman said via email. To learn more click on the picture below to read the article.